Zealand Pharma convenes its Annual General Meeting 2025
February 20, 2025 07:00 ET
|
Zealand Pharma
Company Announcement – No. 3 / 2025 Zealand Pharma convenes its Annual General Meeting 2025 Notice to convene the Annual General Meeting 2025 of Zealand Pharma A/S (CVR no. 20 04 50 78) (the...
Correction: Zealand Pharma Announces Financial Results for the Full Year 2024
February 20, 2025 04:08 ET
|
Zealand Pharma
Company announcement – No. 2 / 2025 Correction includes 2024 Annual Report attached in iXBRL format. Zealand Pharma Announces Financial Results for the Full Year 2024 A transformational year with...
Zealand Pharma Announces Financial Results for the Full Year 2024
February 20, 2025 01:00 ET
|
Zealand Pharma
Company announcement – No. 2 / 2025 Zealand Pharma Announces Financial Results for the Full Year 2024 A transformational year with significant clinical advancement across differentiated obesity...
Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results
February 13, 2025 11:00 ET
|
Zealand Pharma
Press Release – No. 3 / 2025 Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results Copenhagen, Denmark, February 13, 2025 – Zealand Pharma...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
January 13, 2025 11:00 ET
|
Zealand Pharma
Company announcement – No. 1 / 2025 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity
January 07, 2025 11:00 ET
|
Zealand Pharma
Press Release – No. 2 / 2025 Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity Copenhagen, Denmark, January 7, 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL)...
Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th
January 06, 2025 11:00 ET
|
Zealand Pharma
Press Release – No. 1 / 2025 Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th Copenhagen, Denmark, January 6, 2025 – Zealand Pharma A/S (CVR-no....
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
December 25, 2024 11:40 ET
|
Zealand Pharma
Company announcement – No. 53 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
December 25, 2024 11:30 ET
|
Zealand Pharma
Company announcement – No. 52 / 2024 Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc. Copenhagen, Denmark, 25 December 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq:...
U.S. Food and Drug Administration issues Complete Response Letter for the glepaglutide New Drug Application for the treatment of short bowel syndrome
December 19, 2024 14:58 ET
|
Zealand Pharma
Company announcement – No. 51 / 2024 U.S. Food and Drug Administration issues Complete Response Letter for the glepaglutide New Drug Application for the treatment of short bowel syndrome The FDA...